Ilsung Pharmaceuticals Overview
- Year Founded
-
1961
- Status
-
Public
- Employees
-
252
- Stock Symbol
-
003120
- Share Price
-
$12.01
- (As of Monday Closing)
Ilsung Pharmaceuticals General Information
Description
Ilsung Is is a South Korean knowledge-based, technology-intensive, research and development industry, The company specializes in the antibiotics field and produces penicillin antibiotics.
Contact Information
Website
www.ilsungis.comCorporate Office
- 84-gil 9 Wonhyo-ro Yongsan-ku
- Seoul
- South Korea
Corporate Office
- 84-gil 9 Wonhyo-ro Yongsan-ku
- Seoul
- South Korea
Ilsung Pharmaceuticals Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.01 | $12.15 | $11.17 - $21.92 | $82.8M | 6.82M | 3.51K | -$2.17 |
Ilsung Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | (82,554) | (57,671) | (158,367) | 41,417 |
| Revenue | 54,856 | 59,699 | 47,401 | 36,746 |
| EBITDA | (18,924) | (20,414) | 41,214 | 1,102 |
| Net Income | (15,120) | (16,017) | 84,102 | (1,194) |
| Total Assets | 290,892 | 325,286 | 394,916 | 312,081 |
| Total Debt | 141 | 185 | 217 | 152 |
Ilsung Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ilsung Pharmaceuticals Patents
Ilsung Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1931330-A1 | Composition comprising tanshinone compounds isolated from the extract of salviae miltiorrhizae radix for treating or preventing cognitive dysfunction and the use thereof | Inactive | 06-Oct-2005 | ||
| US-20090312413-A1 | Composition comprising tanshinone compounds isolated from the extract of salviae miltiorrhizae radix for treating or preventing cognitive dysfunction and the use thereof | Inactive | 06-Oct-2005 |
Ilsung Pharmaceuticals Executive Team (1)
| Name | Title | Board Seat |
|---|---|---|
| Seok geun Yoon | Chief Executive Officer |
Ilsung Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ilsung Pharmaceuticals FAQs
-
When was Ilsung Pharmaceuticals founded?
Ilsung Pharmaceuticals was founded in 1961.
-
Who is the CEO of Ilsung Pharmaceuticals?
Seok geun Yoon is the CEO of Ilsung Pharmaceuticals.
-
Where is Ilsung Pharmaceuticals headquartered?
Ilsung Pharmaceuticals is headquartered in Seoul, South Korea.
-
What is the size of Ilsung Pharmaceuticals?
Ilsung Pharmaceuticals has 252 total employees.
-
What industry is Ilsung Pharmaceuticals in?
Ilsung Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Ilsung Pharmaceuticals a private or public company?
Ilsung Pharmaceuticals is a Public company.
-
What is Ilsung Pharmaceuticals’s stock symbol?
The ticker symbol for Ilsung Pharmaceuticals is 003120.
-
What is the current stock price of Ilsung Pharmaceuticals?
As of 14-Oct-2024 the stock price of Ilsung Pharmaceuticals is $12.01.
-
What is the current market cap of Ilsung Pharmaceuticals?
The current market capitalization of Ilsung Pharmaceuticals is $82.8M.
-
What is Ilsung Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Ilsung Pharmaceuticals is $54.9M.
-
What is Ilsung Pharmaceuticals’s annual earnings per share (EPS)?
Ilsung Pharmaceuticals’s EPS for 12 months was -$2.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
